logo
Menu

SAINT

Patients

Providers

The Science

Publications

Clinical Trials

Resources

Blog

FAQs

Company

About Us

Newsroom

Careers

Contact

Find a Provider
  • SAINT
  • Patients
  • Providers
  • The Science

    Publications

    Clinical Trials

  • Resources

    Blog

    FAQs

  • Company

    About Us

    Newsroom

    Careers

    Contact

Find a Provider

SMS Terms of Service

Updated April 15, 2026

By providing your mobile phone number and opting in to receive text messages from Magnus Medical, you agree to receive SMS text messages from us at the number you provided, including, as applicable, marketing, promotional, transactional, operational, or account-related messages according to your selection during the opt-in process. Your consent to receive marketing text messages is not a condition of any purchase.

Program Description

The Magnus Medical text messaging program through Hubspot SMS Marketing may include messages relating to SAINT® Depression Therapy marketing information and personalized guidance. The SMS Terms of Service mentions other use cases but this campaign is only for marketing purposes.

The Magnus Medical text messaging program by our Care Navigators may include messages relating to SAINT® Depression Therapy care navigation support and personalized patient guidance.

Message Frequency

Message frequency varies. You may receive up to 50 messages per month.

Autodialed / Automated Messages

Text messages may be sent using an automatic telephone dialing system or other automated technology, where applicable and as permitted by law.

Charges

Message and data rates may apply. Check your mobile carrier plan for details. Carriers are not liable for delayed or undelivered messages.

Opt-in

By opting in, you represent that you are the authorized user of the mobile number provided and that you are authorized to consent to receive text messages at that number.

Opt-Out / Revocation of Consent

You may opt out of receiving text messages at any time by replying STOP to any text message we send. You may also exercise your opt-out rights or revoke consent by contacting us at marketing@magnusmedical.com, 1-888-537-1530, or through any other reasonable method by which you clearly communicate that you no longer wish to receive text messages from us. After we receive your request, we will honor it within a reasonable time in accordance with applicable law. A request to opt out of one type of text message may, where required by law or operationally applied by us, be treated as a request to stop all non-exempt text messages from Magnus to that number.

Help

For help, reply HELP to any message or contact us at marketing@magnusmedical.com or 1-888-537-1530.

Supported Carriers / Delivery

Supported carriers may change without notice. Message delivery is subject to effective transmission by your wireless carrier and is not guaranteed.

Eligibility and Geographic Scope

Our SMS program is intended for recipients in the United States only, unless we expressly state otherwise.

Privacy

Information collected in connection with the SMS program will be handled in accordance with our Privacy Policy, available here: https://www.magnusmedical.com/privacy-policy/

Changes to SMS Program

We may modify or discontinue the SMS program, any of its features, or these SMS terms at any time. We will post updated terms on this page, and your continued participation in the SMS program after such updates become effective constitutes acceptance of the updated terms, to the extent permitted by law.

Contact

If you have questions regarding these SMS terms, please contact us at marketing@magnusmedical.com.

Solutions SAINT Depression Therapy Patients Providers Customer Cloud Login
the science Publications Clinical Trials
Resources Blog FAQs Find a Provider
Company About Us Newsroom Careers Contact
Solutions SAINT Depression Therapy Patients Providers Customer Cloud Login
Resources Blog FAQs Find a Provider
the science Publications Clinical Trials
Company About Us Newsroom Careers Contact
The SAINT® Neuromodulation System is indicated for the treatment of Major Depressive Disorder (MDD) in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. The SAINT Neuromodulation System is contraindicated for: patients with non-removable conductive, ferromagnetic, or other magnetic-sensitive metal anywhere in the head or within 30cm of the stimulation coil; patients who have an active or inactive implanted device; or patients with increased intracranial pressure or intracardiac lines, intravenous pumps, or dose calculators. Consult product labeling for a complete list of contraindications, warnings, and precautions. Side effects including headache, fatigue, anxiety, and treatment-site discomfort were shown in clinical trials. Risks associated with transcranial magnetic stimulation, including seizure and worsening depression or suicidality, may exist. Results may vary.
footer-logo

Copyright © 2026

Privacy Policy Terms of Use Security Trust Center Financial Conflict of Interest Policy